BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2022 8:16:14 AM | Browse: 437 | Download: 913
 |
Received |
|
2021-02-08 07:29 |
 |
Peer-Review Started |
|
2021-02-08 07:33 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-04-06 06:38 |
 |
Revised |
|
2021-04-14 08:39 |
 |
Second Decision |
|
2021-12-31 03:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-12-31 22:24 |
 |
Articles in Press |
|
2021-12-31 22:24 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-12-19 22:32 |
 |
Typeset the Manuscript |
|
2022-01-18 04:34 |
 |
Publish the Manuscript Online |
|
2022-01-21 08:16 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Hepatitis C virus: A critical approach to who really needs treatment
|
Manuscript Source |
Invited Manuscript |
All Author List |
Elias Kouroumalis and Argryro Voumvouraki |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Elias Kouroumalis, MD, PhD, Emeritus Professor, Department of Gastroenterology, University of Crete Medical School, Voutes, Heraklion 71500, Crete, Greece. kouroumi@uoc.gr |
Key Words |
Hepatitis C, Comorbidities, Screening and treatment policy; Hepatitis C virus; Review |
Core Tip |
Elimination of hepatitis C virus (HCV) by 2030 according to the World Health Organization policy seems highly unlikely because of the funding re-direction due to the coronavirus disease 2019 pandemic. It is important therefore to re-evaluate the treatment policies based on a more realistic and feasible approach. HCV disease has a very prolonged natural course, and even HCV-related cirrhosis has a lower mortality compared to other cirrhosis etiologies. However, liver related morbidity and mortality is increased when certain comorbidities accompany the initial HCV infection. A review of the current knowledge allows for a more or less accurate identification of these comorbidities. Therefore, an eradication program is proposed based on screening and treating only these particular groups. |
Publish Date |
2022-01-21 08:16 |
Citation |
Kouroumalis E, Voumvouraki A. HCV: Who really needs treatment. A critical approach. World J Hepatol 2022; 14(1): 1-44 |
URL |
https://www.wjgnet.com/1948-5182/full/v14/i1/1.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v14.i1.1 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345